HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Keijiro Saku Selected Research
Keijiro Saku Research Topics
Disease
37
Coronary Artery Disease (Coronary Atherosclerosis)
01/2019 - 11/2002
32
Hypertension (High Blood Pressure)
05/2019 - 09/2003
26
Myocardial Infarction
10/2021 - 01/2003
26
Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 07/2006
21
Atherosclerosis
01/2018 - 09/2002
15
Atrial Fibrillation
01/2018 - 07/2002
15
Pathologic Constriction (Stenosis)
01/2017 - 10/2003
14
Heart Failure
01/2021 - 12/2003
10
Stable Angina
02/2018 - 01/2008
10
Inflammation (Inflammations)
08/2016 - 04/2004
9
Diabetes Mellitus
08/2016 - 07/2006
8
Acute Coronary Syndrome
11/2020 - 01/2005
8
Essential Hypertension
01/2020 - 03/2003
8
Coronary Restenosis
08/2016 - 10/2003
7
Thrombosis (Thrombus)
03/2017 - 01/2009
7
Coronary Stenosis (Coronary Artery Stenosis)
01/2016 - 10/2003
7
Hypercholesterolemia
01/2012 - 01/2005
6
Stroke (Strokes)
10/2021 - 12/2016
6
Hypertriglyceridemia
12/2020 - 12/2004
6
Coronary Disease (Coronary Heart Disease)
01/2012 - 12/2003
5
Type 2 Diabetes Mellitus (MODY)
01/2020 - 10/2005
5
Atherosclerotic Plaque (Atheroma)
01/2017 - 10/2007
5
Neoplasms (Cancer)
01/2017 - 01/2004
5
Hyperlipidemias (Hyperlipidemia)
03/2011 - 01/2005
5
Cardiomegaly (Heart Hypertrophy)
10/2009 - 01/2003
4
Body Weight (Weight, Body)
05/2017 - 09/2002
4
Ischemia
03/2016 - 04/2007
3
Non-ST Elevated Myocardial Infarction
10/2021 - 09/2020
3
Fibrosis (Cirrhosis)
07/2019 - 06/2003
3
Bradycardia
01/2019 - 06/2009
3
Reperfusion Injury
10/2016 - 02/2010
3
Myocardial Ischemia (Ischemic Heart Diseases)
10/2016 - 04/2007
3
Left Ventricular Dysfunction
01/2009 - 07/2005
3
Dyslipidemias (Dyslipidemia)
08/2008 - 01/2008
2
Chronic Renal Insufficiency
01/2021 - 03/2011
2
ST Elevation Myocardial Infarction
01/2021 - 11/2020
2
Unstable Angina
01/2021 - 01/2019
Drug/Important Bio-Agent (IBA)
22
Cholesterol
IBA
12/2019 - 09/2002
21
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
05/2021 - 02/2004
21
Lipids
IBA
12/2020 - 09/2002
20
oxidized low density lipoprotein
IBA
11/2019 - 04/2004
16
Angiotensin II
IBA
05/2017 - 01/2003
12
Angiotensin II Type 1 Receptor Blockers
IBA
01/2020 - 06/2003
12
LDL Cholesterol
IBA
11/2019 - 09/2002
11
HDL Lipoproteins
IBA
03/2017 - 05/2003
10
Valsartan (Vals)
FDA Link
01/2016 - 09/2003
9
Chymases (Chymase)
IBA
06/2018 - 09/2002
9
HDL Cholesterol
IBA
01/2018 - 04/2004
9
Apolipoprotein A-I (Apolipoprotein A1)
IBA
03/2016 - 02/2004
8
olmesartan
IBA
05/2017 - 07/2009
8
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
IBA
05/2017 - 06/2003
8
Lipoproteins (Lipoprotein)
IBA
05/2010 - 08/2004
7
omega-Chloroacetophenone (Mace)
IBA
10/2021 - 01/2011
7
Apolipoproteins
IBA
12/2020 - 08/2004
7
Calcium Channel Blockers (Blockers, Calcium Channel)
IBA
01/2020 - 02/2004
7
Angiotensin Receptor Antagonists
IBA
05/2017 - 03/2003
7
Losartan (Cozaar)
FDA Link
Generic
12/2015 - 01/2007
7
Adiponectin
IBA
11/2015 - 08/2008
6
LDL Lipoproteins (beta Lipoproteins)
IBA
02/2019 - 04/2004
6
Hydrochlorothiazide (Esidrix)
FDA Link
Generic
02/2017 - 01/2008
6
Atorvastatin (Lipitor)
FDA Link
08/2012 - 04/2004
5
Proteins (Proteins, Gene)
FDA Link
11/2020 - 10/2003
5
Rivaroxaban
IBA
01/2018 - 10/2016
5
Antihypertensive Agents (Antihypertensives)
IBA
12/2016 - 11/2004
5
Peptides (Polypeptides)
IBA
03/2016 - 04/2010
5
Pravastatin (Pravachol)
FDA Link
Generic
12/2008 - 11/2002
4
Triglycerides (Triacylglycerol)
IBA
11/2020 - 11/2006
4
Amlodipine (Norvasc)
FDA Link
Generic
04/2019 - 10/2015
4
Pharmaceutical Preparations
IBA
02/2019 - 08/2003
4
Salts
IBA
06/2018 - 01/2010
4
Anticoagulants
IBA
03/2017 - 01/2009
4
Metals
IBA
08/2016 - 01/2008
4
Irbesartan
FDA Link
Generic
01/2016 - 01/2012
4
C-Reactive Protein
IBA
11/2015 - 01/2006
3
azilsartan
IBA
05/2017 - 01/2013
3
Enzymes
IBA
05/2017 - 10/2003
3
Nitric Oxide (Nitrogen Monoxide)
FDA Link
03/2016 - 04/2008
3
Uric Acid (Urate)
IBA
01/2016 - 01/2007
3
Rosuvastatin Calcium (Crestor)
FDA Link
10/2014 - 09/2009
3
candesartan
IBA
02/2013 - 06/2003
3
Ezetimibe (Zetia)
FDA Link
08/2012 - 01/2008
3
low density lipoprotein inhibitor
IBA
01/2012 - 12/2005
3
Chemokines
IBA
01/2008 - 10/2003
3
Chemokine Receptors
IBA
01/2008 - 10/2003
3
pilsicainide
IBA
01/2006 - 12/2004
2
Lipase (Acid Lipase)
FDA Link
12/2020 - 11/2020
2
Lipoprotein Lipase (Diacylglycerol Lipase)
IBA
12/2020 - 12/2004
2
Apolipoproteins E (ApoE)
IBA
12/2020 - 09/2006
Therapy/Procedure
35
Therapeutics
01/2021 - 03/2003
18
Stents
02/2018 - 01/2005
13
Percutaneous Coronary Intervention
10/2021 - 01/2009
7
Cardiac Rehabilitation
11/2020 - 12/2014
6
Secondary Prevention
10/2021 - 08/2008
4
Catheter Ablation
06/2020 - 07/2002
4
Renal Dialysis (Hemodialysis)
02/2018 - 01/2004
4
Aftercare (After-Treatment)
05/2017 - 04/2012
4
Catheters
01/2016 - 07/2002
3
Drug-Eluting Stents
01/2017 - 02/2013
3
Glycemic Control
05/2015 - 10/2005
3
Coronary Artery Bypass (Coronary Artery Bypass Surgery)
04/2012 - 02/2007